Ratios in Focus: Analyzing Zomedica Corp (ZOM)’s Price-to-Cash and Price-to-Free Cash Flow

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Zomedica Corp (AMEX: ZOM) closed at $0.15 down -5.05% from its previous closing price of $0.16. In other words, the price has decreased by -$5.05 from its previous closing price. On the day, 6.47 million shares were traded. ZOM stock price reached its highest trading level at $0.1551 during the session, while it also had its lowest trading level at $0.147.

Ratios:

For a deeper understanding of Zomedica Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.87 and its Current Ratio is at 11.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 17 ’24 when POWERS JOHNNY D bought 100,000 shares for $0.17 per share. The transaction valued at 17,450 led to the insider holds 2,225,000 shares of the business.

POWERS JOHNNY D bought 25,000 shares of ZOM for $4,600 on May 16 ’24. The Director now owns 2,125,000 shares after completing the transaction at $0.18 per share. On May 14 ’24, another insider, POWERS JOHNNY D, who serves as the Director of the company, bought 50,000 shares for $0.14 each. As a result, the insider paid 6,981 and bolstered with 2,100,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 145522576 and an Enterprise Value of 65064524. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.60 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at 2.506 whereas that against EBITDA is -2.357.

Stock Price History:

Over the past 52 weeks, ZOM has reached a high of $0.25, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -1.19%, while the 200-Day Moving Average is calculated to be -6.56%.

Shares Statistics:

For the past three months, ZOM has traded an average of 5.52M shares per day and 3966740 over the past ten days. A total of 979.95M shares are outstanding, with a floating share count of 963.83M. Insiders hold about 1.64% of the company’s shares, while institutions hold 8.59% stake in the company. Shares short for ZOM as of 1715731200 were 64096234 with a Short Ratio of 11.61, compared to 1713139200 on 60717146. Therefore, it implies a Short% of Shares Outstanding of 64096234 and a Short% of Float of 6.65.

Most Popular